Tag: Ariad Pharmaceuticals Inc.

Finance

Trader’s Recap : Ariad Pharmaceuticals (NASDAQ:ARIA), Trulia (NYSE:TRLA), Hawkins (NASDAQ:HWKN), Compugen Ltd. (NASDAQ:CGEN), Oaktree Capital Group, LLC (NYSE:OAK)

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)’s Director Alexander J. Denner acquired 850,000 shares of Ariad Pharmaceuticals stock on the open market in a transaction dated Aug. 15. The shares were purchased at an average price of $5.83 per share, for a total transaction of $4,955,500.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.46%. On last trading day company shares ended up $6.14. … Continue reading Trader’s Recap : Ariad Pharmaceuticals (NASDAQ:ARIA), Trulia (NYSE:TRLA), Hawkins (NASDAQ:HWKN), Compugen Ltd. (NASDAQ:CGEN), Oaktree Capital Group, LLC (NYSE:OAK)

Jason Knox
Finance

Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

US specialty pharma firm Ariad Pharmaceuticals (NASDAQ:ARIA) has granted Israel’s Medison Pharma exclusive rights to commercialize Iclusig (ponatinib) in Israel for patients with Philadelphia-positive (Ph+) leukemias. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -12.09%. On last trading day company shares ended up $5.38. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -12.94%. Checkpoint Systems, Inc. (NYSE:CKP) … Continue reading Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

Mark Doerr
Finance

Eye Catching Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Informatica (NASDAQ:INFA), Canadian Pacific Railway Limited (NYSE:CP), EnLink Midstream, LLC (NYSE:ENLC), Trex (NYSE:TREX)

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. Currently there are 5 analysts that rate ARIAD Pharmaceuticals a buy, no analysts rate it a sell, and 6 rate it a hold. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)’s stock on 31 July traded at beginning with a price of $6.03 and when day-trade ended the stock … Continue reading Eye Catching Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Informatica (NASDAQ:INFA), Canadian Pacific Railway Limited (NYSE:CP), EnLink Midstream, LLC (NYSE:ENLC), Trex (NYSE:TREX)

John Meady
Finance

Mix Sector Stocks: RadioShack Corp. (NYSE:RSH), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), PFSweb Inc. (NASDAQ:PFSW), Mistras Group, Inc. (NYSE:MG), Telefonica S.A. (ADR) (NYSE:TEF)

Shares of RadioShack Corp. (NYSE:RSH) plummeted nearly 32 percent in extended trading on Wednesday after a Wall Street Journal report revealed that the beleaguered consumer electronics retailer is priming to file for bankruptcy protection as early as the beginning of February after its efforts to improve cash position failed. RadioShack Corp. (NYSE:RSH) belongs to Services sector. Its net profit margin is -13.50% and weekly performance … Continue reading Mix Sector Stocks: RadioShack Corp. (NYSE:RSH), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), PFSweb Inc. (NASDAQ:PFSW), Mistras Group, Inc. (NYSE:MG), Telefonica S.A. (ADR) (NYSE:TEF)

Jason Knox
Finance

Top Stocks: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Pretium Resources Inc. (NYSE:PVG), Nexstar Broadcasting Group, Inc. (NASDAQ:NXST), Xilinx Inc. (NASDAQ:XLNX), Marvell Technology Group (NASDAQ:MRVL)

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) entered into an agreement with Bellicum Pharmaceuticals, Inc. to restructure and amend an existing license agreement between the companies for ARIAD’s cell-signaling technology. Under the terms of the agreement, ARIAD received $15 million upon execution of the agreement and was entitled to receive two payments of $20 million and $15 million by specified dates in the future in exchange for granting … Continue reading Top Stocks: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Pretium Resources Inc. (NYSE:PVG), Nexstar Broadcasting Group, Inc. (NASDAQ:NXST), Xilinx Inc. (NASDAQ:XLNX), Marvell Technology Group (NASDAQ:MRVL)

Harvey Dyer